David A. Mahvi

1.4k total citations
26 papers, 700 citations indexed

About

David A. Mahvi is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Mahvi has authored 26 papers receiving a total of 700 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 11 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Mahvi's work include Pancreatic and Hepatic Oncology Research (5 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers) and Enhanced Recovery After Surgery (4 papers). David A. Mahvi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (5 papers), Cardiac, Anesthesia and Surgical Outcomes (4 papers) and Enhanced Recovery After Surgery (4 papers). David A. Mahvi collaborates with scholars based in United States, Italy and Spain. David A. Mahvi's co-authors include Chandrajit P. Raut, Yolonda L. Colson, Rong Liu, Mark W. Grinstaff, Paul M. Sondel, Jon M. Wigginton, Ilia N. Buhtoiarov, Alexander L. Rakhmilevich, Richard D. Urman and Edward E. Whang and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Journal of Controlled Release.

In The Last Decade

David A. Mahvi

25 papers receiving 694 citations

Peers

Countries citing papers authored by David A. Mahvi

Since Specialization

Citations

This map shows the geographic impact of David A. Mahvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Mahvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Mahvi more than expected).

Fields of papers citing papers by David A. Mahvi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Mahvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Mahvi. The network helps show where David A. Mahvi may publish in the future.

Co-authorship network of co-authors of David A. Mahvi

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Mahvi. A scholar is included among the top collaborators of David A. Mahvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Mahvi. David A. Mahvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Teasing out factors differentiating pathologic from benign pneumatosis intestinalis 2025 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Julia Song, Biqi Zhang, David A. Mahvi, (unknown), Manuel Castillo‐Angeles, Tanujit Dey, (unknown)	0
2	Impact of Obesity on Risk of Hypocalcemia After Total Thyroidectomy: Targeted National Surgical Quality Improvement Program Analysis of 16,277 Patients 2023 ·Journal of Surgical Research ·(unknown), David A. Mahvi, Jason B. Liu, (unknown), Gerard M. Doherty, Matthew A. Nehs, Nancy L. Cho	4
3	Doxorubicin-Loaded Polymeric Meshes Prevent Local Recurrence after Sarcoma Resection While Avoiding Cardiotoxicity 2022 ·Cancer Research ·(unknown), Ngoc-Quynh Chu, (unknown), David A. Mahvi, (unknown), Fumiaki Nagashima, Fumito Ichinose, (unknown), Mark W. Grinstaff, Yolonda L. Colson, Chandrajit P. Raut	5
4	Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death 2022 ·Molecular Cancer Therapeutics ·William A. Blessing, (unknown), (unknown), David A. Mahvi, (unknown), Anil Kumar, Krista J. Hachey, Aaron H. Colby, (unknown), (unknown), Michael S. Regan, Angela Shih, Chandrajit P. Raut, Mark W. Grinstaff, Yolonda L. Colson	1
5	Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings From 2014 to 2019 2022 ·Annals of Surgical Oncology ·Heather Lyu, Pamela Lu, David A. Mahvi, Lindsay E. Kuo, Sandra L. Wong, Chandrajit P. Raut, Nancy L. Cho	2
6	Increased Body Mass Index is Associated With Lower Risk of Hypocalcemia in Total Thyroidectomy Patients 2022 ·Journal of Surgical Research ·David A. Mahvi, Russell G. Witt, Heather Lyu, Atul A. Gawande, Matthew A. Nehs, Gerard M. Doherty, Nancy L. Cho	5
7	Impact of Bariatric Surgery on Endometrial Cancer Tumor Pathology 2021 ·Obesity Surgery ·David A. Mahvi, Olivia Foley, Ali Ardestani, Ali Tavakkoli, Eric G. Sheu	5
8	What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer 2020 ·PubMed ·(unknown), Stephen J. Savage, Aaron Lesher, (unknown), (unknown), Biqi Zhang, David A. Mahvi, David M. Mahvi, Denise I. Garcia, Denise Carneiro‐Pla, (unknown), (unknown), (unknown), (unknown), Sara Giordano, Whitney A. Spannuth Graybill	21
9	The improvement in post-operative mortality following pancreaticoduodenectomy between 2006 and 2016 is associated with an improvement in the ability to rescue patients after major morbidity, not in the rate of major morbidity 2020 ·HPB ·(unknown), David A. Mahvi, Mark Fairweather, Jiping Wang, Thomas E. Clancy, Stanley W. Ashley, Richard D. Urman, Edward E. Whang, Jason S. Gold	25
10	Discharge destination following rectal cancer resection: an analysis of preoperative and intraoperative factors 2019 ·International Journal of Colorectal Disease ·Lily V. Saadat, David A. Mahvi, Joshua S. Jolissaint, Richard D. Urman, Jason S. Gold, Edward E. Whang	8
11	Risk factors and reasons for reoperation after radical cystectomy 2019 ·Urologic Oncology Seminars and Original Investigations ·Stephen W. Reese, (unknown), Marco Paciotti, Jeffrey J. Leow, David A. Mahvi, Graeme S. Steele, Richard D. Urman, Edward E. Whang, Adam S. Kibel, Matthew Mossanen	15
12	Prediction of Discharge Destination Following Major Hepatectomy 2019 ·HPB ·David A. Mahvi, Linda M. Pak, Adam C. Fields, Richard D. Urman, Jason S. Gold, Edward E. Whang	4
13	Utility of Level III Axillary Node Dissection in Melanoma Patients with Palpable Axillary Lymph Node Disease 2019 ·Annals of Surgical Oncology ·David A. Mahvi, Mark Fairweather, Charles H. Yoon, Nancy L. Cho	2
14	Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies 2018 ·CA A Cancer Journal for Clinicians ·David A. Mahvi, Rong Liu, Mark W. Grinstaff, Yolonda L. Colson, Chandrajit P. Raut	243
15	Discharge destination following pancreaticoduodenectomy: A NSQIP analysis of predictive factors and post-discharge outcomes 2018 ·The American Journal of Surgery ·David A. Mahvi, Linda M. Pak, Richard D. Urman, Jason S. Gold, Edward E. Whang	20
16	Enhanced local and systemic anti-melanoma CD8+ T cell responses after memory T cell-based adoptive immunotherapy in mice 2016 ·Cancer Immunology Immunotherapy ·(unknown), Siddhartha Sen, (unknown), David A. Mahvi, (unknown), (unknown), M. Suresh, Clifford S. Cho	13
17	CTLA-4 Blockade Plus Adoptive T-Cell Transfer Promotes Optimal Melanoma Immunity in Mice 2015 ·Journal of Immunotherapy ·David A. Mahvi, (unknown), (unknown), (unknown), M. Suresh, Glen Leverson, Siddhartha Sen, Clifford S. Cho	32
18	Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages 2010 ·Immunology ·Ilia N. Buhtoiarov, Paul M. Sondel, Jon M. Wigginton, (unknown), (unknown), David A. Mahvi, Alexander L. Rakhmilevich	112
19	Inguinal hernias, endometriosis, and other adverse outcomes in rhesus monkeys following lead exposure 2003 ·Neurotoxicology and Teratology ·Lisa Krugner‐Higby, Adam Rosenstein, (unknown), Melissa L. Luck, Nellie K. Laughlin, David A. Mahvi, (unknown)	14
20	Phase I Study of Continuous-Infusion L-S,R-Buthionine Sulfoximine With Intravenous Melphalan 1997 ·JNCI Journal of the National Cancer Institute ·Howard H. Bailey, Gregory H. Ripple, K D Tutsch, R Z Arzoomanian, Dona Alberti, Chris Feierabend, David A. Mahvi, Julian C. Schink, Marcia Pomplun, Ríona Mulcahy, George Wilding	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact